What is the market doing?
What the tape says about RYTM
Rhythm Pharmaceuticals, Inc. is +3.7% over the past year while the S&P 500 is +20%: 17 points behind the market.
+3.7%
1-year return · S&P 500 +20%
- vs 200-day average
- +2.7%
vs 200-day average · close to trend
- RSI (14)
- 22
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 14%
Below its 52-week high
Details›
- Last close2026-09-08
- $101.72
- 1 monthS&P 500 −0.30%
- −9.2%
- 1 yearS&P 500 +20%
- +3.7%
- 5 yearsS&P 500 +85%
- +637%
- vs 50-day average$105.72
- −3.8%
- 52-week high
- $117.62
- 52-week low
- $75.82
- Annualised volatility
- 53%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$931K
| Year | Return |
|---|---|
| 2026 (year to date) | −5.0% |
| 2025 | +91% |
| 2024 | +22% |
| 2023 | +58% |
| 2022 | +192% |
| 2021 | −66% |
| 2020 | +29% |
| 2019 | −15% |
| 2018 | −7.5% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 9 | 3 of 9 | −5.2% |
| Feb | 9 | 3 of 9 | −4.9% |
| Mar | 9 | 1 of 9 | −5.7% |
| Apr | 9 | 5 of 9 | +1.4% |
| May | 9 | 3 of 9 | −4.6% |
| Jun | 9 | 5 of 9 | +6.6% |
| Jul | 9 | 4 of 9 | +25% |
| Aug | 9 | 6 of 9 | +21% |
| Sep | 9 | 3 of 9 | −4.1% |
| Oct | 8 | 3 of 8 | −1.5% |
| Nov | 9 | 7 of 9 | +14% |
| Dec | 9 | 5 of 9 | +4.1% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.